Healthy Overlap Between PTAB And Trial Court Favors Denial, PTAB Litigation Blog
Visit the PTAB Litigation Blog.
The PTAB recently denied institution of inter partes review (IPR) for claims 1 and 46 of U.S. 7,464,040 in eClinicalWorks, LLC et al. v. Decapolis Systems, LLC, IPR2022-0229, Paper 10 (PTAB April 13, 2022). The denial was based on analyzing five of the six factors laid out in Fintiv in light of parallel proceedings related to the same patent. The Petitioners are three of 21 defendants in 14 pending cases in three different district courts, most of which are filed in the Western District of Texas (WDTX). Id. at 3-4. When a patent is involved in parallel proceedings, the PTAB has discretion to denying IPR petitions for the same patent based on six factors identified in Fintiv. Id. at 7.
Insights by Jones Day should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request permission to reprint or reuse any of our Insights, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. This Insight is not intended to create, and neither publication nor receipt of it constitutes, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.
